Screening for obstructive sleep apnoea in post-treatment cancer patients.

Harini SubramanianVeronika FuchsovaElisabeth ElderAlison BrandJulie HowleAnna DeFazioGraham J MannTerence AmisKristina Kairaitis

Published in: Cancer reports (Hoboken, N.J.) (2022)

These screening tools may help identify cancer patients without severe OSA, but both are limited in identifying those with moderate-to-severe or severe OSA. PSG remains optimal for adequately identifying and managing comorbid OSA in cancer patients.

Keyphrases

obstructive sleep apnea
positive airway pressure
early onset
physical activity
drug induced
high intensity
depressive symptoms